European Companies Search Engine
MD (3) · Profit Transfer: ratiopharm GmbH · Control: ratiopharm GmbH · Change of legal form: Aktiengesellschaft BioGeneriX AG · Address · Capital: €1,000,000 · Shareholder agreement · Proxy policy Hrb7 Aug 2012 German Trade Register Announcements, Germany (06/08/2012)
Overview
Text
BioGeneriX GmbH,
Unnamed street ??, 89079 Ulm, Germany
. GmbH. Partnership agreement of July 12, 2012. Business address:
Unnamed street ??, 89079 Ulm, Germany
. Subject: The development, licensing, distribution and marketing of biotechnologically produced pharmaceutical products and preparations for health care, unless official authorisation is required. Share capital: EUR 1,000,000.00. General representation regulation: If only one managing director is appointed, he alone represents. If several managing directors have been appointed, two represent jointly or one managing director with one authorized representative. Managing Director: Dr. ????????, ???????, Neuhausen on the Fildern, *??.??.????; Dr. ????????, ????, Hamburg, *??.??.????; Dr. ??????, ???? ?????, Bellenberg, *??.??.????, each with the power to enter into legal transactions on behalf of the company as a representative of a third party. The company was created by changing the form of the AG "BioGeneriX AG", Ulm (Amtsgericht Ulm HRB 727841) in accordance with Section 190 ff. UmwG. With the "ratiopharm GmbH", Ulm (Amtsgericht Ulm HRB 991), a control and profit transfer agreement was concluded on November 6, 2000 with amendment of January 25, 2001, which was approved by the Annual General Meetings on December 8, 2000 and March 5, 2001. Reference is made to the documents submitted to the court (company contract and consent decisions). As not registered: the creditors of the legal entity involved in the change of form shall be required to provide security within six months of the date on which they are required to declare their claim in writing in advance of the date on which the entry of the change of form in the register of the registered office of the entity of which they are creditors is deemed to have been made known in § 19 Abs. 3 UmwG, provided that they cannot claim satisfaction. However, creditors are only entitled to this right if they demonstrate that the change of form jeopardises the fulfilment of their claim.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: BioGeneriX GmbH, Ulm, Germany.